E-Cigarettes Have Only Short-Term Effect On Smoking Cessation: Study

In recent years, e-cigarettes have been widely marketed as a safer alternative to smoking, though critics say they increase the risk of life-long nicotine additions from vaping among prior non-smokers. Now, the findings of a new study suggest that even among cigarette smokers, any benefit provided by e-cigarettes in helping them quit appears to be effective for only a short period of time.

Canadian researchers indicate that use of e-cigarettes to help quit smoking, along with counseling, is twice as effective than counseling alone at first. However, the benefit only appears to be short term., according to findings published this week in the Journal of the American Medical Association (JAMA).

Researchers conducted a randomized clinical trial enrolling 376 adults. Participants were randomized to a nicotine e-cigarettes plus counseling group, a non-nicotine e-cigarettes plus counseling group, or a counseling alone group. The study ran from November 2016 to September 2019 at 17 Canadian sites.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The data indicates using e-cigarettes with nicotine plus smoking cessation counseling had a significantly greater effect on helping users quit smoking traditional tobacco cigarettes. Abstinence was 22% at 12 weeks for the combo group, compared to only 9% for smoking cessation counseling alone. However, by 24 weeks the difference was not as significant. The combo group had an abstinence rate of 17%, compared to 10% in the counseling-only group.

This could be because e-cigarettes may be just as addictive as traditional cigarettes. This can increase a person’s dependence on nicotine overall, even if it is a different method of delivery. Some users may return to cigarette smoking after using e-cigarettes.

The findings of the new study also focused on a third group that used non-nicotine e-cigarettes and counseling. The abstinence rate was not significantly different from counseling alone at 12 weeks, 17% had stopped smoking compared to 9%. However, by the 24 week mark the rate increased to 20% for the combo group using non-nicotine e-cigarettes and counseling compared to 10% for counseling only.

Adverse events were common in all groups, The most common was cough and dry mouth. Roughly 64% of participants experienced cough and 53% dry mouth.

Most of the study participants were long-time smokers and had tried other methods of quitting. Many people advocate e-cigarettes as a method of quitting tobacco cigarettes, but research indicates quitting e-cigarettes may be even harder than quitting traditional cigarettes. This may be due to the high delivery rates of nicotine in many e-cigarette devices.

E-cigarettes also expose users to carcinogenic chemicals, much like tobacco cigarettes, and increase their risk of respiratory issues and problems with blood flow and can lead to heart attacks and strokes.

“Among adults motivated to quit smoking, nicotine e-cigarettes plus counseling vs counseling alone significantly increased point prevalence abstinence at 12 weeks,” the researchers concluded. “However, the difference was no longer significant at 24 weeks, and trial interpretation is limited by early termination and inconsistent findings for nicotine and nonnicotine e-cigarettes, suggesting further research is needed.”

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.